(NASDAQ: HCM) Hutchmed's forecast annual revenue growth rate of 15.05% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 4.59%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.8%.
Hutchmed's revenue in 2025 is $630,201,000.On average, 1 Wall Street analysts forecast HCM's revenue for 2025 to be $495,496,506,497, with the lowest HCM revenue forecast at $495,496,506,497, and the highest HCM revenue forecast at $495,496,506,497. On average, 1 Wall Street analysts forecast HCM's revenue for 2026 to be $514,244,646,050, with the lowest HCM revenue forecast at $514,244,646,050, and the highest HCM revenue forecast at $514,244,646,050.
In 2027, HCM is forecast to generate $836,562,730,981 in revenue, with the lowest revenue forecast at $836,562,730,981 and the highest revenue forecast at $836,562,730,981.